Basal and postglucagon C-peptide levels in Ethiopians with diabetes

Diabetes Care

Volumn 25, Issue 3, 2002, Pages 453-457

  Siraj, Elias S ^a   Reddy, S Sethu K ^a   Scherbaum, Werner A ^b   Abdulkadir, Jemal ^c   Hammel, Jeffrey P ^a   Faiman, Charles ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCAGON; INSULIN;

ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; ETHIOPIA; HORMONE BLOOD LEVEL; HOSPITAL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; ADULT; BLOOD; DRUG EFFECT; FEMALE; MALE; REFERENCE VALUE; SOCIOECONOMICS;

ADULT; C-PEPTIDE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; ETHIOPIA; FEMALE; GLUCAGON; HUMANS; INSULIN; MALE; REFERENCE VALUES; SOCIOECONOMIC FACTORS;

EID: 0036518144     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.3.453     Document Type: Article

References (33)

1. Scheen AJ, Castillo MJ, Lefebvre PJ: Assessment of residual insulin secretion in diabetic patients using the intravenous glucagon stimulatory test: methodological aspects and clinical applications (Review). Diabete Metab 22:397-406, 1996
2. World Health Organization: WHO Expert Committee on Diabetes Mellitus. Second Report. Geneva, World Health Org., 1980 (Tech. Rep. Ser., no. 646)
3. World Health Organization: Diabetes Mellitus: Report of a WHO Study Group. Geneva, World Health Org., 1985 (Tech. Rep. Ser., no. 727)
4. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1057, 1979
5. Gjessing HJ, Matzen LE, Faber OK, Froland A: Fasting plasma C-peptide, glucagon stimulated plasma C-peptide, and urinary C-peptide in relation to clinical type of diabetes. Diabetologia 32:305-311, 1989
6. Service FJ, Rizza RA, Zimmerman BR, Dzck PJ, O'Brien PC, Melton LJ III: The classification of diabetes by clinical and C-peptide criteria: a prospective population-based study. Diabetes Care 20:198-201, 1997
7. Welborn TA, Garcia-Webb P, Bonser AM: Basal C-peptide in the discrimination of type I from type II diabetes. Diabetes Care 4:616-619, 1981
8. Vahlkamp T, Lutjens A, Nauta EH: The glucagon-stimulated C-peptide test: an aid in classification of patients with diabetes mellitus. Neth J Med 36:196-199, 1990
9. Lee A, Bray GA, Morley JE: Stimulated C-peptide and glucose levels as metabolic criteria to use insulin treatment in adult-onset type 2 diabetes. Endocr Pract 2:183-190, 1996
10. Landin-Olsson M, Nilsson KO, Lernmark A, Sundkvist G: Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus. Diabetologia 33:561-568, 1990
11. Juang JH, Huang HS, Huang MJ: C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus. J Formos Med Assoc 91:491-496, 1992
12. Madsbad S, Krarup T, McNair P, Christiansen C, Faber OK, Transbol I, Binder C: Practical clinical value of the C-peptide response to glucagon stimulation in the choice of treatment in diabetes mellitus. Acta Med Scand 210:153-156, 1981
13. Kalk WJ, Joannou J, Ntsepo S, Mahomed I, Mahanlal P, Becker PJ: Ethnic differences in the clinical and laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European and Indian origins. J Intern Med 241:31-37, 1997
14. Omar MA, Asmal AC: C-peptide response to glucagon in black and Indian insulin-dependent diabetics. S Afr Med J 61:395-397, 1982
15. Bella AF, Adelaja B, John-Alo C, Adetuyibi A: Insulin secretory reserve in diabetic Nigerian Africans. Afr J Med Sci 19:39-42, 1990
16. Otim MA: A prospective study of glucose profiles, insulin antibody levels and beta cells secretory patterns in non-obese Ugandan diabetic subjects. East Afr Med J 65:8-15, 1988
17. Abdulkadir J, Mengesha B, Welde-Gebriel Z, Keen H, Worku Y, Gebre P, Bekele A, Urga K, Tadesse AS: The clinical and hormonal (C-peptide and glucagon) profile and liability to ketoacidosis during nutritional rehabilitation in Ethiopian patients with malnutrition-related diabetes mellitus. Diabetologia 33:222-227, 1990
18. Ahren B, Corrigan CB, Alberti KGMM: Plasma insulin and C-peptide responses to oral glucose in newly diagnosed diabetics in north-western Tanzania. East Afr Med J 65:847-851, 1988
19. Papoz L, Delcourt C, Ponton-Sanchez A, Lokrou A, Darrack R, Toure IA, Cuisinier-Raynal JC: Clinical classification of diabetes in tropical West Africa. Diabetes Res Clin Pract 39:219-227, 1998
20. Egger G: The case for using waist to hip ratio measurements in routine medical checks: a review. Med J Aust 156:280-285, 1992
21. Siraj ES, Gupta MK, Faiman C, Reddy SSK: GAD65 and IA-2 antibody detection using a combi-assay in Ethiopians with diabetes mellitus (Abstract). Diabetes 49 (Suppl. 1):A410, 2000
22. Grasso YZ, Reddy SK, Rosenfeld C, Hussein W, Hoogwerf BJ, Faiman C, Gupta MK: Autoantibodies to GAD65 and IA-2 in patients with type 2 diabetes mellitus of variable duration: prevalence and correlation with clinical features. Endocr Pract 7:339-345, 2001.
23. Zimmet PZ, Tuomi T, Mackay IR, Rowley MJ, Knowles W, Cohen M, Lang DA: Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency. Diabet Med 11:299-303, 1994
24. Bogardus Clifton: Insulin resistance in the pathogenesis of NIDDM in Pima Indians. Diabetes Care 16 (Suppl. 1):S228-S231, 1993
25. Haffner SM, Stern MP, Hazuda HP, Rosenthal M, Knapp JA, Malina RM: The role of obesity and fat distribution in non-insulin dependent diabetes mellitus in Mexican Americans and non-Hispanic whites. Diabetes Care 9:153-161, 1986
26. O'Dea K: Westernisation, insulin resistance and diabetes in Australian Aborigines: a review. Med J Aust 155:258-264, 1991
27. Osei K, Ezenwaka EC, Cottrel DA, Akanji AO, Adenuwon CA, O'Dorisio TM: Serum insulin and glucose concentrations in people at risk for type 2 diabetes: a comparative study of African Americans and Nigerians. Diabetes Care 16:1367-1375, 1993
28. Shires R, Joffe BI, Seftel HC: Maximal pancreatic beta-cell stimulation and the counter-regulatory hormonal responses in South African black and white obese subjects. S Afr Med J 67:845-847, 1985
29. Nihalani KD, Varthakavi PK, Patel KL, Merchant PC: C-peptide profiles in young diabetics. J Assoc Physicians India 41:345-9, 1993
30. Bjoerntorp P: Regional fat distribution: implication for type II diabetes. Int J Obes 16 (Suppl. 4):S19-S27, 1992
31. Dowse GK, Gareeboo H, Zimmet PZ: The high prevalence of glucose intolerance in Indian, Creole and Chinese Mauritians. Diabetes 39:390-396, 1990
32. Haffner SM, Stern MP, Hazuda HP: Do upper-body and centralized adiposity measure different aspects of regional body-fat distribution? Relationship to NIDDM, lipids and lipoproteins. Diabetes 36:43-51, 1987
33. Peters WH, Belay D: Ernaehrungsanthropometrie bei gesunden und diabetischen Aethiopiern. 2. Koerpergewicht und koerperzusammensetzung von insulinabhaengigen diabetikern. Z Klin Med 44:51-57, 1989